AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
MOMETASONE FUROATE MONOHYDRATE
17 registrations across 5 African markets— 17 active
Markets with MOMETASONE FUROATE MONOHYDRATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| MOMEX Nasal Spray | 🇰🇪Kenya | Dafra Pharma GmbH | active | Aug 2030 |
| NORHINOSE Nasal Spray Nasal Spray | 🇷🇼Rwanda | EUROPEAN EGYPTIAN PHARMACEUTICAL INDUSTRIES | active | Feb 2030 |
| ELICA OINTMENT | 🇬🇭Ghana | — | active | Oct 2029 |
| ELICA OINTMENT | 🇬🇭Ghana | — | active | Oct 2029 |
| MOMEX Nasal spray | 🇷🇼Rwanda | DEVA HOLDING A.?. | active | Aug 2029 |
| NASONEX NASAL SPRAY (Each metered dose contains: Mometasone furoate monohydrate 50 micrograms/actuation) | 🇬🇭Ghana | MSD(PTY) LIMITED, PRIVATE BAG 3 HALFWAY HOUSE MIDRAND 1685, SOUTH AFRICA | active | Aug 2029 |
| NASONEX NASAL SPRAY (Each metered dose contains: Mometasone furoate monohydrate 50 micrograms/actuation) | 🇬🇭Ghana | MSD(PTY) LIMITED, PRIVATE BAG 3 HALFWAY HOUSE MIDRAND 1685, SOUTH AFRICA | active | Aug 2029 |
| MOMAGEX | 🇿🇦South Africa | Adcock Ingram Limited | active | Feb 2029 |
| MOMETASONE ADCO | 🇿🇦South Africa | Adcock Ingram Limited | active | Feb 2029 |
| ELOCOM OINTIMENT OINTIMENT ( Mometasone furoate monohydrate 10mg) | 🇬🇭Ghana | — | active | Dec 2026 |
| ELOCOM OINTIMENT OINTIMENT ( Mometasone furoate monohydrate 10mg) | 🇬🇭Ghana | — | active | Dec 2026 |
| ELOCOM CREAM | 🇬🇭Ghana | — | active | Dec 2026 |
| ELOCOM CREAM | 🇬🇭Ghana | — | active | Dec 2026 |
| MOMETASONE
FUROATE
MONOHYDRATE NASAL SYSTEMIC
METERED-DOSE
LIQUIDS | 🇺🇬Uganda | ORGANON SOUTH AFRICA (PTY) LTD | active | — |
| MOMETASONE
FUROATE
MONOHYDRATE NASAL SYSTEMIC
METERED-DOSE
LIQUIDS | 🇺🇬Uganda | GLENMARK PHARMACEUTICA LS LTD | active | — |
| MOMETASONE
FUROATE
MONOHYDRATE NASAL SYSTEMIC
METERED-DOSE
LIQUIDS | 🇺🇬Uganda | GLENMARK PHARMACEUTICA LS LTD | active | — |
| MOMETASONE
FUROATE
MONOHYDRATE NASAL SYSTEMIC
METERED-DOSE
LIQUIDS | 🇺🇬Uganda | ORGANON SOUTH AFRICA (PTY) LTD | active | — |
MOMETASONE FUROATE MONOHYDRATE in Africa — Regulatory Overview
MOMETASONE FUROATE MONOHYDRATE is registered across 5 African markets with 17 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Uganda, Rwanda, South Africa and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 17 registrations, 17 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.